Neuromics is a bioreagents company providing human cells, media, sera, and plenty more for neuroscience, cancer, pain, and more research.
Minneapolis, MN
Joined March 2009
- Tweets6.9K
- Following456
- Followers559
- Likes1.3K
Neuromics retweeted
The Long COVID thread is doing well, but the story of this bacterium is much bigger than just Long COVID.
*F. prausnitzii* depletion shows up consistently in:
• Parkinson’s (including gut-first cases)
• Alzheimer’s
• Colorectal cancer
• Autoimmune diseases
• Type 2 diabetes
• And even in healthy centenarians
I just published a bigger summary article pulling all of this together.
Here’s the full picture in an article.
xitter.cf/Neuroscope_mp/status/2…
Neuromics retweeted
🚨BREAKING: A UC consortium trial just launched the most precise CRISPR attack on sickle cell disease yet — directly correcting the broken gene itself, not just working around it.
This changes everything!!
Neuromics retweeted
A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, raising hopes that it may help to beat the deadly condition newscientist.com/article/252…
Neuromics retweeted
🚨 BREAKING
For 40 years, pancreatic cancer's deadliest gene, KRAS, was called "undruggable."
A pill just nearly DOUBLED survival in a Phase 3 trial.
The method used is so cool!
ASCO 2026 may have just changed cancer history. 🧵
#ASCO2026 #PancreaticCancer #CancerResearch
Neuromics retweeted
Demis Hassabis says he can cure every disease in 10 years.
Most people roll their eyes when they hear this, but I don't.
Demis is the guy who just won the Nobel Prize for solving protein folding with AI (a problem biologists had been stuck on for 50 years).
But that was just one milestone in his much grander plan.
In 2010, he founded DeepMind with a 2-part mission: "solve intelligence, then use it to solve everything else."
Step 1: make AI good enough to do real science.
Step 2: point that AI at humanity's biggest problems.
Step one was AlphaFold.
He used AI to figure out the 3D shape of every protein in nature (which is basically what every drug attaches to).
Demis said it would have taken "a billion years of PhD time" to do by hand.
Step two is curing all disease.
And as of today, step two is fully funded.
Isomorphic Labs (his AI drug discovery company inside Google) just raised $2.1B led by Thrive Capital.
Here's where the money goes and what Demis thinks happens next:
> Drug discovery currently takes 5-10 years and costs billions per drug. That math is why most diseases don't have good treatments today.
> AI fixes the math. Their drug design engine compresses development from years to months. Maybe weeks.
> Isomorphic's first AI-designed cancer drug enters human trials this year.
> Their pipeline expands beyond the current 17 programs across cancer, immune diseases, and heart disease into more health domains.
> The endgame is personalized medicine: drugs designed overnight for your specific biology and your specific disease.
That last one is the whole point.
Today's drugs are mass-produced for an "average" patient who doesn't really exist.
So most existing treatments work inconsistently from person to person, and most rare diseases never get a treatment at all (no market = no drug).
When drug design gets fast and cheap, that whole calculus flips.
Cancer variants get drugs designed for that specific variant, rare diseases get treatments because economics stop mattering, and drug-resistant infections get new drugs faster than they can evolve.
That's what curing every disease actually looks like.
Now imagine what your life looks like in 2036.
A doctor draws your blood, sequences your genome, sends your disease profile to an AI.
By morning the AI has designed a custom drug for your specific biology.
Side effects, dosage, drug interactions all worked out before you take the first pill.
You and your kids never see a cancer ward.
That's what $2.1B is buying today.
Demis was right about AlphaFold.
If you consider the possibility that he's right again, every disease alive today is on borrowed time.
I’ve always believed the No.1 application of AI should be to improve human health.
That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease!
We are turbocharging that goal with $2.1B in new funding.
Neuromics retweeted
A highly detailed and medically accurate 3D model of the human nervous system.
📽: SciePro
Neuromics retweeted
🚨 BREAKING:
Most people don't know that certain diseases dramatically raise their risk of developing Parkinson's.
This isn't speculation. It's peer-reviewed science involving millions of patients.
Some of these conditions are treatable, and treating them may lower your risk.
Here's what the research actually says 🧵👇
Neuromics retweeted
🚨 BREAKING: Scientists in China grew brain cells in a lab, implanted them into Parkinson's patients, and saw real dopamine come back.
Now the FDA has approved this therapy for Phase 1 in the US.
This is XS-411.
And it might be the most important stem cell story you haven't heard.
🧵 Thread 👇
Neuromics retweeted
BREAKING: The FDA approved a cancer drug in 2024 that doesn't use chemotherapy.
Instead, it powers up the immune cells you were BORN with.
In trials, 62% of patients had all detectable cancer disappear completely.
This is not hype. Here's what it actually is —
and why it doesn't stop with cancer. 🧵
Neuromics retweeted
Repetitive negative thinking is associated with cognitive decline.
A positive mindset is a superpower.
The new Huberman Lab episode is out: Unlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (@HealthyGamerGG)
0:00 Alok Kanojia (Dr. K)
3:09 Internet, Computer Games; Academic Pressure
7:11 Millennials & Self-Awareness, Hijacking Mental Health Language
13:24 Sponsors: Lingo & Joovv
16:06 Personality & Individual Road Maps, Misdiagnosis
22:02 Ambiguity, Flirting, Social Skills Decline, Uncertainty Tolerance
26:06 Dating in the Internet Age, Cognitive Bias
30:39 Healthy Distress Tolerance, Tool: How to Feel Your Feelings
39:58 Sponsor: AG1
40:49 Expectations vs Internal Desire Roadmap, Western vs Eastern Theory of Mind, Ego
50:35 Sense Organs, Comparison & Proving Oneself, Internal Drive
59:22 Internet, Ego, "Teflon Buddha", Tool: Dealing with Criticism
1:10:36 Observing One's Mind, Meditation, Psychedelics
1:11:59 Sponsor: Function
1:13:46 Tool: Shunya "Void" Meditation & Resilience
1:24:02 External Reminders, Environment; Men & Emotional Regulation
1:30:04 Samskara, Yoga Nidra, Trauma & Learning, Shunya & Personal Compass
1:39:15 Yoga Nidra, Channeling Divinity, Genius
1:42:30 Sponsor: Eight Sleep
1:43:48 Breathwork Practices; Meditation Science, Self-Esteem & Belief Change
1:53:40 Liminal States, Meditation Types & Benefits; Western & Eastern Balance
2:01:50 Understanding Ego & Perception; AI & Narcissism, Psychosis
2:14:07 Tool: Healthy Social Media Use, When To Not Use, Normal Standards
2:18:38 Social Media & Looks Obsession, Purpose, Charisma
2:24:18 Young Men Falling Behind?, Male Support, Suicide; Men in Relationships
2:30:36 "Stuck" Young Men, Failure to Launch, Tool: Motivation & Understanding Oneself
2:39:03 Pornography, Erectile Dysfunction, Emotions, Addiction; Relationships
2:44:21 Men & Love, Looksmaxxing, Rejection, Partner Characteristics, Tool: Walk Before Dates
2:55:12 Exploring Practices, Meditation, Breathwork
3:01:39 Spirituality, Personal Exploration; Acknowledgements
3:06:12 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter
Includes paid partnerships.
Neuromics retweeted
Gut Microbiome Reset Reduces Brain Inflammation
Healing a traumatic brain injury (TBI) might actually start in the digestive system. A new study reveals that short-term antibiotic treatment can significantly reduce neuroinflammation and brain cell death following a TBI
neurosciencenews.com/microbi…
Neuromics retweeted
Spark curiosity and ignite a passion for biology with Smart Biology’s Animated Textbooks! Our interactive 3D lessons transform complex concepts into captivating experiences, helping students truly understand and explore the wonders of science. Ready to empower learning? Dive in at smart-biology.com! #EduTech #SmartLearning #biology #3D #science #animation
Neuromics retweeted
🚨 A Japanese scientist earned a Nobel Prize after discovering one of the body’s most powerful self-healing mechanisms: during periods of fasting, the human body begins to consume its own damaged cells, triggering a deep cellular reset known as autophagy. This natural process acts like an internal cleanup system, breaking down old proteins, malfunctioning components, and toxic buildup that contribute to aging and disease. The discovery revealed that fasting doesn’t just change metabolism — it activates a fundamental survival program hard-wired into our biology.
Researchers found that autophagy boosts cellular renewal, supports immune function, protects against neurodegeneration, and improves overall resilience. When the body isn’t busy digesting food, it shifts focus to maintenance and repair, recycling damaged parts into fresh, healthy components. This helps reduce inflammation, sharpen brain function, and improve the body’s ability to handle stress. Some studies even show that activating autophagy may lower the risk of chronic conditions linked to aging.
The Nobel-winning research transformed how scientists view fasting, turning it from a simple diet trend into a legitimate biological reset. Doctors now say intermittent fasting — when done safely — can help support long-term cellular health, boost energy, and improve metabolic balance. While it’s not a cure-all, the discovery showed that the body has extraordinary built-in abilities to heal itself when given the right conditions.
For millions around the world, the research opened a new window into how deeply our lifestyle affects our cells — and how something as simple as timing our meals can unlock one of the body’s most powerful repair systems.
ALT A Japanese scientist earned a Nobel Prize after discovering one of the body’s most powerful self-healing mechanisms: during periods of fasting, the human body begins to consume its own damaged cells, triggering a deep cellular reset known as autophagy. This natural process acts like an internal cleanup system, breaking down old proteins, malfunctioning components, and toxic buildup that contribute to aging and disease. The discovery revealed that fasting doesn’t just change metabolism — it activates a fundamental survival program hard-wired into our biology. Researchers found that autophagy boosts cellular renewal, supports immune function, protects against neurodegeneration, and improves overall resilience. When the body isn’t busy digesting food, it shifts focus to maintenance and repair, recycling damaged parts into fresh, healthy components. This helps reduce inflammation, sharpen brain function, and improve the body’s ability to handle stress.
Neuromics retweeted
Otto Loewi’s vagusstoff discovery showed how the vagus nerve acts like a brake on heart rate. Nearly 75 years later, our lab’s work showed that vagus nerve signaling acts like a brake on cytokine release and inflammation. The “inflammatory reflex” opened the door to bioelectronic therapies for RA, and likely soon, other autoimmune diseases.
As summarized in an article published with the title “Shock Medicine” in Scientific American Magazine Vol. 312 No. 3 (March 2015), p. 28
Neuromics retweeted
Scientists from the University of Oxford and University College London are preparing to launch what would be the world’s first clinical trial of a vaccine aimed at preventing lung cancer, expected to begin in summer 2026.
The experimental vaccine, known as LungVax, will initially be tested in people considered at high risk of developing lung cancer, including individuals who have previously been treated for early-stage disease.
Rather than treating existing cancer, LungVax is designed to stimulate the immune system to recognise and eliminate abnormal lung cells before they can develop into tumours.
The planned trial will monitor safety, determine appropriate dosing, and measure immune responses over a study period of up to four years.
Neuromics retweeted
BREAKTHROUGH: AI just learned to spot cancer mutations humans often miss, directly from DNA and RNA.
Researchers at Hong Kong have just developed powerful deep-learning algorithms that dramatically improve how genetic mutations are detected in cancer and RNA sequencing. The study introduces ClairS-TO and Clair3-RNA, two AI models designed to work with long read sequencing, allowing scientists to analyze much larger and more complex genetic regions than traditional methods.
ClairS-TO is especially important for cancer research because it can identify somatic mutations from tumor DNA without needing a matched normal sample, something that is often unavailable in real clinical settings. It uses a dual deep-learning network to separate true cancer mutations from sequencing noise, improving reliability in tumor only analysis.
Meanwhile, Clair3-RNA is the first deep learning model built specifically for small variant detection in long read RNA sequencing. RNA data is notoriously noisy due to editing and transcription errors, but this model can distinguish real genetic variants from artifacts, enabling researchers to study gene expression and mutations simultaneously.
These tools mark a major step toward faster, more accurate AI driven precision medicine.
Neuromics retweeted
New issue: cell.com/neuron/current
The cover highlights a Review article from 24 co-authors that discusses the principles of brain clearance, including the role of CSF influx, sleep-dependent waste removal, and connections to the immune system. Art by Nadia Alzoubi.
Neuromics retweeted
***New Human Primary Cells for Diabetes Research***
Create, Discover & Innovate
Neuromics keeps its fingers on the pulse of cell-based assays required by our Bio-Pharma, Academic, and Government Labs. We specialize in providing two and three-dimensional Assays for disease modeling
We are accelerating our addition of solutions for Diabetes therapeutics research neuromics.com/new-human-cell….
Image: Formation of tube networks in Neuromics HRMECs in normal glucose (NG) and high glucose (HG) conditions.
Here are the new cell types:
*ADSCs - Obesity Donor (cat. ADSC001)
*ADSCs - Type 1 Diabetes Donor (cat. ADSC002)
*ADSCs - Type 2 Diabetes Donor (cat. ADSC003)
*Dermal Fibroblasts - Type 1 Diabetes Donor (cat. HDF002)
*Hepatic Stellate Cells - NASH Donor (cat. HHSC001)
Along with the cells, we offer a comprehensive range of growth media, coating solutions, and more to facilitate their growth.
The release of these new cell types will build on the existing use of our cells to study these common diseases. To keep current, please follow our showcase page linkedin.com/company/neuromi….
